Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker

RT @ArthritisRes: Serum amyloid A may be a better RA biomarker than CRP, especially during treatment with TNF antagonists https://t.co/jQkz…

RT @ArthritisRes: Serum amyloid A may be a better RA biomarker than CRP, especially during treatment with TNF antagonists https://t.co/jQkz…

Serum amyloid A may be a better RA biomarker than CRP, especially during treatment with TNF antagonists https://t.co/jQkzzxyFce #rheumedu